Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cryofocus Medtech (Shanghai) Co. Ltd. Class H ( (HK:6922) ) has provided an announcement.
Cryofocus Medtech has received approval from the National Medical Products Administration for a registration change of its disposable cryoprobe, a component of the Cryoadhesion System. This approval is expected to enhance the commercialization pathway of the system, allowing it to address medical indications more effectively, thus potentially strengthening the company’s market position in respiratory medical technologies.
More about Cryofocus Medtech (Shanghai) Co. Ltd. Class H
Cryofocus Medtech (Shanghai) Co., Ltd. operates in the medical technology industry, focusing on respiratory interventional products. The company is known for its Cryoadhesion System, which utilizes advanced refrigeration and heat transfer technologies for medical procedures such as cryoremoval and cryobiopsy.
Average Trading Volume: 86,934
Technical Sentiment Signal: Hold
Current Market Cap: HK$1.28B
See more data about 6922 stock on TipRanks’ Stock Analysis page.